1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Clinical Supply Management
  6.  » Optimizing Direct-to-Patient Clinical Supply for Decentralized Clinical Trials

Optimizing Direct-to-Patient Clinical Supply for Decentralized Clinical Trials

Summary: With coronavirus inhibiting the traditional approach to clinical trials, many companies are adopting the decentralized trial approach. Decentralized trials were on-the-rise even before the pandemic, boasting higher recruitment and retention rates for patients who prefer trials without the logistical challenges of in-clinic attendance.

Click here to view the webinar